Disease: Borderline Personality Disorder ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0006012
Disease: Borderline Personality Disorder
Borderline Personality Disorder 		0.020 Biomarker disease BEFREE In the present study, we aimed to investigate the role of DNA methylation of APBA3 and MCF2 as possible biomarkers for treatment outcome in BPD, whilst validating the previous findings of differential DNA methylation in a cohort of 44 BPD patients and 44 well-matched healthy control individuals. 29274998 2018
CUI: C0006012
Disease: Borderline Personality Disorder
Borderline Personality Disorder 		0.020 GeneticVariation disease BEFREE Bead chip technology and quantitative bisulfite pyrosequencing showed a significantly increased methylation at CpG sites of APBA2 (1.1 fold) and APBA3 (1.1 fold), KCNQ1 (1.5 fold), MCF2 (1.1 fold) and NINJ2 (1.2 fold) in BPD patients. 24367640 2013